Current status of immunotherapy of patients with HIV-infectionHERSH, E. M.International journal of immunopharmacology. 1991, Vol 13, pp 9-18, issn 0192-0561, SUP1Article

Sensitivity of multiple myeloma to imexon in the human tumor cloning assaySALMON, S. E; HERSH, E. M.Journal of the National Cancer Institute. 1994, Vol 86, Num 3, pp 228-230, issn 0027-8874Article

Characterization of small and large human peripheral blood monocytes: effects of in vitro maturation on hydrogen peroxide release and on the response to macrophage activatorsTURPIN, J; HERSH, E. M; LOPEZ-BERESTEIN, G et al.The Journal of immunology (1950). 1986, Vol 136, Num 11, pp 4194-4198, issn 0022-1767Article

Delayed hypersensitivity responses of cancer patients to recall antigens using a new multitest applicatorREUBEN, J. M; HERSH, E. M.Annals of allergy. 1984, Vol 53, Num 5, pp 390-394, issn 0003-4738Article

The AIDS epidemic: AIDS research in the life sciencesHERSH, E. M; PETERSEN, E. A.Life sciences (1973). 1988, Vol 42, Num 20, issn 0024-3205, I-IVArticle

Simple method for adapting DNA fragments and PCR products to all of the commonly used restriction sitesTSANG, T. C; HARRIS, D. T; AKPORIAYE, E. T et al.BioTechniques. 1996, Vol 20, Num 1, pp 51-52, issn 0736-6205Article

A human monoclonal antimelanoma single-chain Fv antibody derived from tumor-infiltrating lymphocytesHUA ZHANG; LAKE, D. F; BARBUTO, J. A. M et al.Cancer research (Baltimore). 1995, Vol 55, Num 16, pp 3584-3591, issn 0008-5472Article

Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitroHERSH, E. M; GSCHWIND, C. R; TAYLOR, C. W et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 16, pp 1238-1244, issn 0027-8874Article

Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitroROBINSON, W. E; KAWAMURA, T; LAKE, D et al.Journal of virology. 1990, Vol 64, Num 11, pp 5301-5305, issn 0022-538X, 5 p.Article

Phenotypic analyses of lymphokine-activated killer cells that release interferon γ and tumor necrosis factor αCHONG, A. S.-F; YBARRONDO, B; GRIMES, W. J et al.Cancer immunology and immunotherapy. 1990, Vol 31, Num 4, pp 255-259, issn 0340-7004, 5 p.Article

A hybridoma producing human monoclonal antibody specific for glycoprotein 120kDa of human immunodeficiency virus (HIV-1)LAKE, D; SUGANO, T; MATSUMOTO, Y et al.Life sciences (1973). 1989, Vol 45, Num 16, pp iii-x, issn 0024-3205, 8 p.Article

Idiopathic production of interleukin-1 in acquired immune deficiency syndromeLEPE-ZUNIGA, J. L; MANSELL, P. W. A; HERSH, E. M et al.Journal of clinical microbiology (Print). 1987, Vol 25, Num 9, pp 1695-1700, issn 0095-1137Article

Clinical pharmacology of the biological response modifier maleic anhydride divinyl ether copolymer (MVE-2)ROSENBLUM, M. G; RIOS, A. M; HERSH, E. M et al.Cancer chemotherapy and pharmacology. 1986, Vol 18, Num 3, pp 243-246, issn 0344-5704Article

Decreased adenosine deaminase (ADA) and 5' nucleotidase (SNT) activity in peripheral blood T cells in Hodgkin diseaseMURRAY, J. L; PEREZ-SOLER, R; BYWATERS, D et al.American journal of hematology. 1986, Vol 21, Num 1, pp 57-66, issn 0361-8609Article

Effect of azimexon therapy on host defense parameters and disease-associated symptoms in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC)PATT, Y. Z; MANSELL, P. W. A; REUBEN, J. M et al.AIDS research. 1986, Vol 2, Num 3, pp 191-209, issn 0737-6006Article

Distribution of technetium-99m-labeled multilamellar liposomes in patients with Hodgkin's diseasePEREZ-SOLER, R; LOPEZ-BERESTEIN, G; KASI, L. P et al.Journal of nuclear medicine. 1985, Vol 26, Num 7, pp 743-749, issn 0097-9058Article

Volatile nitrites: use and adverse effects related to the current epidemic of deficiency syndromeNEWELL, G. R; MANSELL, P. W. A; SPITZ, M. R et al.The American journal of medicine. 1985, Vol 78, Num 5, pp 811-816, issn 0002-9343Article

Alpha interferon for induction of remission in hairy-cell leukemiaQUESADA, J. R; REUBEN, J; MANNING, J. T et al.The New England journal of medicine. 1984, Vol 310, Num 1, pp 15-18, issn 0028-4793Article

Immunological characterizations of patients with acquired immune deficiency syndrome, acquired immune deficiency syndrome-related symptom complex, and a related life-styleHERSH, E. M; MANSELL, P. W. A; REUBEN, J. M et al.Cancer research (Baltimore). 1984, Vol 44, Num 12, pp 5894-5901, issn 0008-5472, 1Article

T cell surface antigen expression on lymphocytes of patients with AIDS during in vitro mitogen stimulationMUNN, C. G; REUBEN, J. M; HERSH, E. M et al.Cancer immunology and immunotherapy. 1984, Vol 18, Num 3, pp 141-148, issn 0340-7004Article

Novel antitumor 2-cyanoaziridine-1-carboxamidesIYENGAR, B. S; DORR, R. T; ALBERTS, D. S et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 3, pp 510-514, issn 0022-2623Article

Comparison of 4- and 24-hour intravenous infusion schedules for granulocyte-macrophage colony-stimulating factorWONG, L; TAYLOR, C. W; RADWANSKI, E et al.Journal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 1, pp 57-65, issn 1067-5582Article

Molecular cloning, expression and mutagenesis of an anit-insulin single chain Fv (scFv)LAKE, D. F; LAM, K. S; PENG, L et al.Molecular immunology. 1994, Vol 31, Num 11, pp 845-856, issn 0161-5890Article

Suppression of human lymphoma development in the severe combined immune-deficient mouse by imexon therapyHERSH, E. M; GROGAN, T. M; FUNK, C. Y et al.Journal of immunotherapy. 1993, Vol 13, Num 2, pp 77-83, issn 1053-8550Article

A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas : a Southwest oncology group studyBROWN, T. D; GOODMAN, P; FLEMING, T et al.Journal of immunotherapy. 1991, Vol 10, Num 5, pp 376-378, issn 1053-8550Article